Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Johannes Kreuzer, Ph.D.

Concepts (145)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Johannes Kreuzer's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Johannes Kreuzer has written about over time.
Oleic Acid, 1 publications between 2018 and 2018, average publication date August 2018. Stearic Acids, 1 publications between 2018 and 2018, average publication date August 2018. Phosphopeptides, 1 publications between 2019 and 2019, average publication date August 2019. Mass Spectrometry, 3 publications between 2018 and 2021, average publication date October 2019. Chromatography, Liquid, 2 publications between 2019 and 2021, average publication date June 2020. Proteome, 2 publications between 2019 and 2021, average publication date September 2020. Proteomics, 3 publications between 2019 and 2021, average publication date December 2020. CREB-Binding Protein, 1 publications between 2021 and 2021, average publication date January 2021. E1A-Associated p300 Protein, 1 publications between 2021 and 2021, average publication date January 2021. Haptoglobins, 1 publications between 2021 and 2021, average publication date July 2021. Macrophage Activation, 1 publications between 2021 and 2021, average publication date November 2021. Systemic Inflammatory Response Syndrome, 2 publications between 2021 and 2022, average publication date March 2022. Glycolysis, 2 publications between 2021 and 2024, average publication date October 2022. Alkylating Agents, 1 publications between 2023 and 2023, average publication date March 2023. Apolipoprotein E2, 1 publications between 2024 and 2024, average publication date March 2024. Plaque, Amyloid, 1 publications between 2024 and 2024, average publication date March 2024. Bile Duct Neoplasms, 1 publications between 2024 and 2024, average publication date May 2024. Cholangiocarcinoma, 1 publications between 2024 and 2024, average publication date May 2024. Receptor, Fibroblast Growth Factor, Type 2, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Kreuzer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (145)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.